X-Linked Retinal Dysplasia Overview

Save information for later
Sign Up

Learn About X-Linked Retinal Dysplasia

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top X-Linked Retinal Dysplasia Local Doctors?
Elite in X-Linked Retinal Dysplasia
Elite in X-Linked Retinal Dysplasia
Tokyo, JP 

Tatsushi Toda practices in Tokyo, Japan. Toda is rated as an Elite expert by MediFind in the treatment of X-Linked Retinal Dysplasia. Their top areas of expertise are Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, Thrombectomy, and Thymectomy.

Elite in X-Linked Retinal Dysplasia
Elite in X-Linked Retinal Dysplasia
Shinjuku, JP 

Keiko Ishigaki practices in Shinjuku, Japan. Ms. Ishigaki is rated as an Elite expert by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Fukuyama Type Muscular Dystrophy, Walker-Warburg Syndrome, Lissencephaly, X-Linked Retinal Dysplasia, and Thymectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in X-Linked Retinal Dysplasia
Elite in X-Linked Retinal Dysplasia
Shinjuku, JP 

Takatoshi Sato practices in Shinjuku, Japan. Sato is rated as an Elite expert by MediFind in the treatment of X-Linked Retinal Dysplasia. Their top areas of expertise are X-Linked Retinal Dysplasia, Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, and Thymectomy.

What are the latest X-Linked Retinal Dysplasia Clinical Trials?
Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Summary: Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Congenital Muscle Disease Patient and Proxy Reported Outcome Study

Summary: The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...